中国化学涉康得新案卷入41亿连带赔偿 总营收几乎原地踏步1950亿目标难期

Core Viewpoint - China Chemical is involved in a lawsuit related to the financial fraud case of Kangde Xin, with potential claims amounting to 4.139 billion yuan from investors due to false statements [1][4][5]. Group 1: Lawsuit Details - China Chemical's subsidiary, Ningbo Engineering Co., received a lawsuit notification regarding claims against Kangde Xin for investment losses due to false statements [1][4]. - The plaintiffs are seeking compensation for investment losses, including a total claim of 4.139 billion yuan [1][4]. - China Chemical has stated that its subsidiary was not aware of any financial fraud by Kangde Xin and does not expect the lawsuit to materially impact its profits [1][4]. Group 2: Financial Performance - In the first three quarters of 2025, China Chemical reported a revenue of 136.3 billion yuan, achieving 69.9% of its annual target [3][9]. - To meet its 2025 revenue goal of 195 billion yuan, the company needs to generate 58.7 billion yuan in the fourth quarter, representing a 13.17% increase from the previous year [3][9]. - The company has experienced stagnant revenue growth in recent years, with a reported revenue of 186.613 billion yuan in 2024, a 4.14% increase year-on-year [7][8]. Group 3: Future Outlook - China Chemical plans to achieve a new contract signing target of 370 billion yuan and a revenue target of 195 billion yuan by 2025 [2][8]. - The company has successfully completed a nylon new materials project, which is expected to enhance production efficiency and market competitiveness [10]. - The chairman of China Chemical has expressed a commitment to significantly improve the company's quality and performance over the next five years [10].

CNCEC-中国化学涉康得新案卷入41亿连带赔偿 总营收几乎原地踏步1950亿目标难期 - Reportify